Geriatr Nephrol Urol. 1999 ; 9(1): 39-48.

Medical management of benign prostatic hyperplasia.

Chacon A, Monga M.

Division of Urology, University of California, San Diego, USA.

The management of benign prostatic hyperplasia has undergone a rapid evolution over the past decade from a surgical emphasis to a medical emphasis. Great strides in the development of alpha-adrenergic blockers, 5 alpha-reductase inhibitors and a variety of phytotherapeutics have fueled this evolution. This article reviews the past, present and future of the medical management of benign prostatic hyperplasia.